Health Catalyst, Inc (HCAT)

From the record

Health Catalyst, Inc's filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Health Catalyst, Inc's 9 filed years say what it did: revenue went from $73 million in fiscal 2017 to $311 million in fiscal 2025, up 19.9% a year; it rose in 8 of 8 years; it never fell from a peak; net income was positive in 0 of 9 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Health Catalyst, Inc lost about 72 cents for every dollar of shareholders' money. Leverage: it owed about 51 cents per dollar of assets, and net share issuance: its share count grew 16.1% over the year (the filed statements).

From the record

Health Catalyst, Inc's standing among 73 graded names in its industry family: revenue of $311 million in fiscal 2025 ranks in the bottom 47% by size; a net margin of -57.2% ranks in the bottom 20%; revenue growth of 4% a year over the last 3 filed years ranks in the bottom 39% (its annual reports).

From the record

Health Catalyst, Inc's leadership, from its insiders' filings and its current reports: the chief executive on the record is Kohl, Simeon (Chief Executive Officer, as filed), filing under that title since 2026-09-16, 2 months (bottom 2% of its family); the 16 officers and directors filing in the last fifteen months have been on the record a median of 2.3 years (bottom 11%); 13 officer or director changes were reported on Form 8-K since 2023-11-13, against the 16 people in charge now (bottom 23%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Health Catalyst, Inc's room to grow, from the newest filed statements (fiscal 2025): cash of $51 million against debt of $152 million leaves -20.1% of its assets as net cash, bottom 24% of its family; cash from operations less capital spending is -0.1% of revenue (bottom 37%); research spending of 16% of revenue (top 50%) (its annual report).

From the record

Health Catalyst, Inc's growth drivers, from the filed years to fiscal 2025: revenue grew 4% a year over the last three filed years against 19.9% over all 9, slowing (bottom 26% of its family); the newest year grew 1.5% (bottom 31%); research spending grew -13% a year (bottom 18%); capital spending grew -23.6% a year (bottom 22%) (its annual reports). Health Catalyst, Inc reported 2 lines of business in fiscal 2025: Technology at $208 million (67%), Professional Services at $103 million (33%); 1 of 2 grew against the year before (its annual report).

From the record

Health Catalyst, Inc's newest year against its own record: revenue of $311 million in fiscal 2025 came in 3.7% below the $323 million its prior three years' pace pointed to (bottom 36% of its family); net income of $178 million against a prior three-year average of $108 million (bottom 18%); a net margin of -57.2% against -37.4% before (bottom 15%) (its annual reports).